Fractyl Health Overview
Valuation check: GUTS's ROE is 6345.35%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow6345.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GUTS is 6345.35%. That is above the sector sector average of -5.68%. Investors often review this figure alongside Fractyl Health's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, GUTS currently prints 6345.35% for ROE, while the sector average sits near -5.68%. That is roughly 111751.6% above the sector mean. Large gaps often invite a closer look at Fractyl Health's growth, margins, and balance sheet.
Return on Equity shows how effectively Fractyl Health converts resources into returns. At 6345.35%, GUTS may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GUTS's ROE (6345.35%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
